Lv3
358 积分 2025-08-04 加入
Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab
7小时前
已完结
Reduced-dose obinutuzumab induces remission in refractory ANCA-associated vasculitis: a report of 16 cases
7小时前
已完结
Combination therapy with rituximab and cyclophosphamide for remission induction in ANCA vasculitis
7小时前
已完结
Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis
7小时前
已完结
Low-dose rituximab as induction therapy for ANCA-associated vasculitis
7小时前
已完结
EFFICACY OF ULTRA-LOW DOSE RITUXIMAB FOR REMISSION MAINTENANCE THERAPY IN ANCA-ASSOCIATED VASCULITIS
4天前
求助中
B cell and anti-PLA2R antibody-guided rituximab therapy in idiopathic membranous nephropathy: a prospective multi-center cohort study in the East Coastal Region of China
4天前
已完结
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
2个月前
已完结
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
2个月前
已完结
Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis
2个月前
已完结
皖公网安备34019202002308
